Alzheimer's disease brain-derived amyloid-β-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein
- PMID: 21593310
- PMCID: PMC6622598
- DOI: 10.1523/JNEUROSCI.6500-10.2011
Alzheimer's disease brain-derived amyloid-β-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein
Abstract
Synthetic amyloid-β protein (Aβ) oligomers bind with high affinity to cellular prion protein (PrP(C)), but the role of this interaction in mediating the disruption of synaptic plasticity by such soluble Aβ in vitro is controversial. Here we report that intracerebroventricular injection of Aβ-containing aqueous extracts of Alzheimer's disease (AD) brain robustly inhibits long-term potentiation (LTP) without significantly affecting baseline excitatory synaptic transmission in the rat hippocampus in vivo. Moreover, the disruption of LTP was abrogated by immunodepletion of Aβ. Importantly, intracerebroventricular administration of antigen-binding antibody fragment D13, directed to a putative Aβ-binding site on PrP(C), prevented the inhibition of LTP by AD brain-derived Aβ. In contrast, R1, a Fab directed to the C terminus of PrP(C), a region not implicated in binding of Aβ, did not significantly affect the Aβ-mediated inhibition of LTP. These data support the pathophysiological significance of SDS-stable Aβ dimer and the role of PrP(C) in mediating synaptic plasticity disruption by soluble Aβ.
Figures



Similar articles
-
Cellular Prion Protein Mediates the Disruption of Hippocampal Synaptic Plasticity by Soluble Tau In Vivo.J Neurosci. 2018 Dec 12;38(50):10595-10606. doi: 10.1523/JNEUROSCI.1700-18.2018. Epub 2018 Oct 24. J Neurosci. 2018. PMID: 30355631 Free PMC article.
-
Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.Neurobiol Dis. 2016 Jul;91:124-131. doi: 10.1016/j.nbd.2016.03.001. Epub 2016 Mar 3. Neurobiol Dis. 2016. PMID: 26949218 Free PMC article.
-
Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Aβ in vivo.Philos Trans R Soc Lond B Biol Sci. 2013 Dec 2;369(1633):20130147. doi: 10.1098/rstb.2013.0147. Print 2014 Jan 5. Philos Trans R Soc Lond B Biol Sci. 2013. PMID: 24298149 Free PMC article.
-
Cellular prion protein as a therapeutic target in Alzheimer's disease.J Alzheimers Dis. 2014;38(2):227-44. doi: 10.3233/JAD-130950. J Alzheimers Dis. 2014. PMID: 23948943 Review.
-
Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease.Arch Neurol. 2009 Nov;66(11):1325-8. doi: 10.1001/archneurol.2009.223. Arch Neurol. 2009. PMID: 19901162 Free PMC article. Review.
Cited by
-
Prion-Protein-interacting Amyloid-β Oligomers of High Molecular Weight Are Tightly Correlated with Memory Impairment in Multiple Alzheimer Mouse Models.J Biol Chem. 2015 Jul 10;290(28):17415-38. doi: 10.1074/jbc.M115.643577. Epub 2015 May 27. J Biol Chem. 2015. PMID: 26018073 Free PMC article.
-
The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc).J Neurosci. 2012 Jun 27;32(26):8817-30. doi: 10.1523/JNEUROSCI.1103-12.2012. J Neurosci. 2012. PMID: 22745483 Free PMC article.
-
Peripheral Interventions Enhancing Brain Glutamate Homeostasis Relieve Amyloid β- and TNFα- Mediated Synaptic Plasticity Disruption in the Rat Hippocampus.Cereb Cortex. 2017 Jul 1;27(7):3724-3735. doi: 10.1093/cercor/bhw193. Cereb Cortex. 2017. PMID: 27390019 Free PMC article.
-
Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer's Disease.Virol Sin. 2019 Oct;34(5):475-488. doi: 10.1007/s12250-019-00124-1. Epub 2019 May 15. Virol Sin. 2019. PMID: 31093882 Free PMC article. Review.
-
Anti-PrPC antibody rescues cognition and synapses in transgenic alzheimer mice.Ann Clin Transl Neurol. 2019 Feb 27;6(3):554-574. doi: 10.1002/acn3.730. eCollection 2019 Mar. Ann Clin Transl Neurol. 2019. PMID: 30911579 Free PMC article.
References
-
- Balducci C, Beeg M, Stravalaci M, Bastone A, Sclip A, Biasini E, Tapella L, Colombo L, Manzoni C, Borsello T, Chiesa R, Gobbi M, Salmona M, Forloni G. Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc Natl Acad Sci U S A. 2010;107:2295–2300. - PMC - PubMed
-
- Bi X, Gall CM, Zhou J, Lynch G. Uptake and pathogenic effects of amyloid beta peptide 1-42 are enhanced by integrin antagonists and blocked by NMDA receptor antagonists. Neuroscience. 2002;112:827–840. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials